169 related articles for article (PubMed ID: 6117373)
1. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion.
Mohammed R; Clark JS; Adams JF; Hearns JB; Crean GP
Clin Ther; 1981; 4(2):118-20. PubMed ID: 6117373
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
3. The new histamine H2-receptor antagonist ranitidine. Duration of action.
Dammann HG; Simon B
Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
[TBL] [Abstract][Full Text] [Related]
4. [Effect of ranitidine on secretion of gastric intrinsic factor and absorption of vitamin B 12].
Bélaïche J; Zittoun J; Marquet J; Nurit Y; Yvart J
Gastroenterol Clin Biol; 1983 Apr; 7(4):381-4. PubMed ID: 6135642
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine: a pilot study in Japan.
Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
[TBL] [Abstract][Full Text] [Related]
6. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
Gabryelewicz A; Sarosiek J; Laszewicz W
Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
[No Abstract] [Full Text] [Related]
7. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
Weingart J; Kunert H; Ottenjann R
Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
[TBL] [Abstract][Full Text] [Related]
8. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
[TBL] [Abstract][Full Text] [Related]
9. Oral ranitidine for prophylaxis against Mendelson's syndrome.
Francis RN; Kwik RS
Anesth Analg; 1982 Feb; 61(2):130-2. PubMed ID: 6119931
[TBL] [Abstract][Full Text] [Related]
10. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
Lazzaroni M; Bianchi Porro G
Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
[TBL] [Abstract][Full Text] [Related]
11. [Side effects and safety of the new histamine H2 receptor antagonist ranitidine in the long-term treatment of patients with stomach and duodenal ulcers].
Meryn S; Pötzi R; Brunner H; Pesendorfer FX; Pamperl H
Wien Klin Wochenschr; 1983 Apr; 95(9):310-2. PubMed ID: 6137111
[TBL] [Abstract][Full Text] [Related]
12. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
13. A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.
Brittain RT; Daly MJ
Scand J Gastroenterol Suppl; 1981 Jun; 69():1-9. PubMed ID: 6119770
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
[TBL] [Abstract][Full Text] [Related]
15. Histamine H2-receptor antagonists.
Feldman M; Richardson CT
Adv Intern Med; 1978; 23():1-24. PubMed ID: 24327
[TBL] [Abstract][Full Text] [Related]
16. [Ranitidine, a new histamine H2 receptor antagonist. First experimental and clinical data].
Simon B; Dammann HG; Müller P; Kather H
Minerva Med; 1981 Oct; 72(40):2657-61. PubMed ID: 6117040
[TBL] [Abstract][Full Text] [Related]
17. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
Simon B; Müller P; Dammann HG
Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
[TBL] [Abstract][Full Text] [Related]
18. Comparative study with ranitidine and cimetidine on gastric secretion.
Sewing KF; Billian A; Malchow H
Scand J Gastroenterol Suppl; 1981 Jun; 69():45-9. PubMed ID: 6119782
[TBL] [Abstract][Full Text] [Related]
19. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
Domschke W; Lux G; Domschke S
Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
[TBL] [Abstract][Full Text] [Related]
20. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
Noya G; Dettori G; Antona C; Niolu P; Muscas A; Marongiu G; Biglioli P
Minerva Med; 1983 Mar; 74(13):691-3. PubMed ID: 6132353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
